+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031 by Component, Modality, Setting, and Country: Trend Forecast and Growth Opportunity

  • PDF Icon

    Report

  • 105 Pages
  • April 2022
  • Region: Asia Pacific
  • GMD Research
  • ID: 5582313
Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic.



Highlighted with 28 tables and 41 figures, this 105-page report “Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, Homecare, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country.

Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Catheters
  • Sensors
  • Monitoring Devices
  • Probes
  • Other Components

Based on Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Invasive Monitoring
  • Minimally Invasive Monitoring
  • Non-Invasive Monitoring

By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospitals
  • Clinics
  • Ambulatory Care Units
  • Homecare
  • Other Settings

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Baxter International Inc.
  • Caretaker, LLC
  • Cheetah Medical Inc.
  • CN Systems Medizintechnik GmbH
  • Deltex Medical Group PLC
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Flosonics Medical
  • GE Healthcare
  • Getinge Group
  • Heart Kinetics
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Lidco Group PLC
  • Masimo Corporation
  • NI Medical Ltd.
  • Osypka Medical GmbH
  • Retia Medical
  • Schwarzer Cardiotek
  • Sramek BioDynamics Inc.
  • Uscom Ltd.
Frequently Asked Questions about the Asian Pacific Hemodynamic Monitoring Systems Market

What is the estimated value of the Asian Pacific Hemodynamic Monitoring Systems Market?

The Asian Pacific Hemodynamic Monitoring Systems Market was estimated to be valued at $271.5 Million in 2021.

What is the growth rate of the Asian Pacific Hemodynamic Monitoring Systems Market?

The growth rate of the Asian Pacific Hemodynamic Monitoring Systems Market is 8.0%, with an estimated value of $587.5 Million by 2031.

What is the forecasted size of the Asian Pacific Hemodynamic Monitoring Systems Market?

The Asian Pacific Hemodynamic Monitoring Systems Market is estimated to be worth $587.5 Million by 2031.

Who are the key companies in the Asian Pacific Hemodynamic Monitoring Systems Market?

Key companies in the Asian Pacific Hemodynamic Monitoring Systems Market include Baxter International Inc., Caretaker, LLC, Cheetah Medical Inc., CN Systems Medizintechnik GmbH, Deltex Medical Group PLC, Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Flosonics Medical and Getinge Group.

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Component
3.1 Market Overview by Component
3.2 Catheters
3.3 Sensors
3.4 Monitoring Devices
3.5 Probes
3.6 Other Components

4 Segmentation of Asia Pacific Market by Modality
4.1 Market Overview by Modality
4.2 Invasive Monitoring
4.3 Minimally Invasive Monitoring
4.4 Non-Invasive Monitoring

5 Segmentation of Asia Pacific Market by Setting
5.1 Market Overview by Setting
5.2 Hospitals
5.3 Clinics
5.4 Ambulatory Care Units
5.5 Homecare
5.6 Other Settings

6 Asia-Pacific Market 2021-2031 by Country
6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • Baxter International Inc.
  • Caretaker, LLC
  • Cheetah Medical Inc.
  • CN Systems Medizintechnik GmbH
  • Deltex Medical Group PLC
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Flosonics Medical
  • GE Healthcare
  • Getinge Group
  • Heart Kinetics
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Lidco Group PLC
  • Masimo Corporation
  • NI Medical Ltd.
  • Osypka Medical GmbH
  • Retia Medical
  • Schwarzer Cardiotek
  • Sramek BioDynamics Inc.
  • Uscom Ltd.

List of TablesTable 1. Snapshot of Asia Pacific Hemodynamic Monitoring Systems Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Worldwide Diabetes Prevalence, 2000 - 2045
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Hemodynamic Monitoring Systems Market
Table 6. Asia Pacific Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn
Table 7. Asia Pacific Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn
Table 8. Asia Pacific Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn
Table 9. APAC Hemodynamic Monitoring Systems Market by Country, 2021-2031, $ mn
Table 10. Japan Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn
Table 11. Japan Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn
Table 12. Japan Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn
Table 13. China Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn
Table 14. China Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn
Table 15. China Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn
Table 16. Australia Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn
Table 17. Australia Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn
Table 18. Australia Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn
Table 19. India Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn
Table 20. India Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn
Table 21. India Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn
Table 22. South Korea Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn
Table 23. South Korea Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn
Table 24. South Korea Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn
Table 25. Hemodynamic Monitoring Systems Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 26. Baxter International Inc.: Company Snapshot
Table 27. Baxter International Inc.: Business Segmentation
Table 28. Baxter International Inc.: Product Portfolio

List of FiguresFigure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Industry Value Chain Analysis
Figure 5. Asia Pacific Hemodynamic Monitoring Systems Market, 2021-2031, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Hemodynamic Monitoring Systems Market
Figure 8. Worldwide Prevalence of Cardiovascular Disorders, 1990-2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Hemodynamic Monitoring Systems Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Five Forces Analysis of Asia Pacific Hemodynamic Monitoring Systems Market
Figure 14. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Component, 2021-2031, % of Revenue
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)
Figure 16. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Catheters, 2021-2031, $ mn
Figure 17. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Sensors, 2021-2031, $ mn
Figure 18. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Monitoring Devices, 2021-2031, $ mn
Figure 19. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Probes, 2021-2031, $ mn
Figure 20. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Other Components, 2021-2031, $ mn
Figure 21. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Modality, 2021-2031, % of Sales Revenue
Figure 22. Asia Pacific Addressable Market Cap in 2022-2031 by Modality, Value ($ mn) and Share (%)
Figure 23. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Invasive Monitoring, 2021-2031, $ mn
Figure 24. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Minimally Invasive Monitoring, 2021-2031, $ mn
Figure 25. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Non-Invasive Monitoring, 2021-2031, $ mn
Figure 26. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Setting, 2021-2031, % of Sales Revenue
Figure 27. Asia Pacific Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%)
Figure 28. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Hospitals, 2021-2031, $ mn
Figure 29. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Clinics, 2021-2031, $ mn
Figure 30. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Ambulatory Care Units, 2021-2031, $ mn
Figure 31. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Homecare, 2021-2031, $ mn
Figure 32. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Other Settings, 2021-2031, $ mn
Figure 33. Breakdown of APAC Hemodynamic Monitoring Systems Market by Country, 2021 and 2031, % of Revenue
Figure 34. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 35. Hemodynamic Monitoring Systems Market in Japan, 2021-2031, $ mn
Figure 36. Hemodynamic Monitoring Systems Market in China, 2021-2031, $ mn
Figure 37. Hemodynamic Monitoring Systems Market in Australia, 2021-2031, $ mn
Figure 38. Hemodynamic Monitoring Systems Market in India, 2021-2031, $ mn
Figure 39. Hemodynamic Monitoring Systems Market in South Korea, 2021-2031, $ mn
Figure 40. Hemodynamic Monitoring Systems Market in Rest of APAC, 2021-2031, $ mn
Figure 41. Growth Stage of Asia Pacific Hemodynamic Monitoring Systems Industry over the Forecast Period

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Baxter International Inc.
  • Caretaker, LLC
  • Cheetah Medical Inc.
  • CN Systems Medizintechnik GmbH
  • Deltex Medical Group PLC
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Flosonics Medical
  • GE Healthcare
  • Getinge Group
  • Heart Kinetics
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Lidco Group PLC
  • Masimo Corporation
  • NI Medical Ltd.
  • Osypka Medical GmbH
  • Retia Medical
  • Schwarzer Cardiotek
  • Sramek BioDynamics Inc.
  • Uscom Ltd.

Methodology

Loading
LOADING...